Showing results (91-100 of 597) with videos related to

Sort By:
Pageof 60
Cancer Diagnosis & Prognosis|January 5, 2026
Recurrence of Low-risk Non-muscle-invasive Bladder Cancer in Patients Who Did Not Receive Immediate Intravesical ChemotherapyAkinori Minato, Kazumasa Jojima, Shuki Watanabe, et al.
Cancer Diagnosis & Prognosis|March 6, 2023
Clinical Outcomes of Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung CancerYutaro Tasaki, Kazuto Ashizawa, Daisuke Nakamura, et al.
Cancer Diagnosis & Prognosis|March 6, 2023
Discontinuation of Immune Checkpoint Inhibitor due to irAEs in NSCLC Patients With EGFR MutationShinichiro Okauchi, Kunihiko Miyazaki, Toshihiro Shiozawa, et al.
Cancer Diagnosis & Prognosis|March 6, 2023
Pharmacodynamic Modeling Identifies Synergistic Interaction Between Chloroquine and Trastuzumab in Refractory HER2- positive Breast Cancer CellsYesenia L Franco, Christine Khan, Sihem Ait-Oudhia
Cancer Diagnosis & Prognosis|March 6, 2023
NSCLC Patients Achieving Long-term Progression-free Survival With Docetaxel Plus Ramucirumab: A Retrospective StudyKunihiko Miyazaki, Toshihiro Shiozawa, Shinichiro Okauchi, et al.
Cancer Diagnosis & Prognosis|March 6, 2023
Palliative Radiotherapy Induced Severe Tumor Lysis Syndrome in a Patient With Multiple Myeloma With Skin Involvement: A Case Report and Review of LiteratureTerufumi Kawamoto, Tatsuki Karino, Yoichi Muramoto, et al.
Cancer Diagnosis & Prognosis|March 6, 2023
Real-world Data of Paclitaxel and Cetuximab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckSantiago Aguin, Alberto Carral, Leticia Iglesias, et al.
Cancer Diagnosis & Prognosis|May 11, 2023
Significance of the Prognostic Immune and Nutritional Index in Patients With Stage I-III Colorectal CancerMasatsune Shibutani, Shinichiro Kashiwagi, Tatsunari Fukuoka, et al.
Cancer Diagnosis & Prognosis|May 11, 2023
Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial CarcinomaTeruo Inamoto, Ryo Sato, Yuto Matsushita, et al.
Cancer Diagnosis & Prognosis|May 11, 2023
Clinicopathological and Prognostic Relevance of Tumoral Suppression of Tumorigenicity 2 Expression in Patients With Surgically Resected Pancreatic CarcinomaMamiko Nagase, Emi Ibuki, Reiji Haba, et al.
Pageof 60